Dengue Author: Suranjith L. Seneviratne, MD, DPhil, MRCP, FRCPath; Panduka Karunanayake, MD, MRCP; Bandula Wijesiriwardena, MD, FRCP, FCCP, FCMSA, FRACP, FACP
Editorial changes - 2009-11-13
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up
Tables
Figures
References
Glossary
What's New
Patient Information
Additional Resources
Tools
What's New
Newly Cited References
2009-02-01A clinical guide for early detection of dengue fever and timing of investigations to detect patients likely to develop complications.
2009-02-01Corticosteroids in the treatment of dengue illness.
2009-01-02Stable introduction of a life-shortening Wolbachia infection into the mosquito Aedes aegypti.
2009-01-01Threat of dengue to blood safety in dengue-endemic countries.
2008-12-26Early clinical features of dengue infection in Puerto Rico.
2008-12-01Detection of concurrent infection with multiple dengue virus serotypes in Thai children by ELISA and nested RT-PCR assay.
2008-11-01Geographic expansion of dengue: the impact of international travel.
2008-11-01Evaluation of immunological markers in serum, filter-paper blood spots, and saliva for dengue diagnosis and epidemiological studies.
2008-11-01Clinical and laboratory features that distinguish dengue from other febrile illnesses in endemic populations.
2008-11-01Imported infectious diseases and surveillance in Japan.
2008-10-01Skin lesions in hospitalized cases of dengue fever.
2008-08-20Evaluation of two new commercial tests for the diagnosis of acute dengue virus infection using NS1 antigen detection in human serum.
2008-08-01Clinical and laboratory characteristics and risk factors for fatality in elderly patients with dengue hemorrhagic fever.
2007-12-01Lack of efficacy of high-dose intravenous immunoglobulin treatment of severe thrombocytopenia in patients with secondary dengue virus infection.

New References of Interest
2009-06-09Community involvement in dengue vector control: cluster randomised trial.
FAQs
Bandula Wijesiriwardena, MD, FRCP, FCCP, FCMSA, FRACP, FACP has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Panduka Karunanayake, MD, MRCP has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Suranjith L. Seneviratne, MD, DPhil, MRCP, FRCPath has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.

The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.